3M CompanyMMM
NYSE • Industrials
$149.17
P/E
24.88
PEG
—
FCF Yield
—
Rev Growth YoY
+152.0% YoY
Gross Margin
3992.0%
Health Score
4/10
D/E Ratio
2.65
Confidence
LOW
Business Snapshot
3M Company is a diversified industrial conglomerate operating across segments including safety & industrial, transportation & electronics, and healthcare, selling products ranging from adhesives and abrasives to medical supplies and consumer goods. The company trades on the NYSE under the Industrials sector and competes globally across a wide range of end markets. Based on available price and ratio data, 3M sits firmly in the large-cap tier, though a precise market capitalisation figure is not available in this payload.
Financial Health
Score: 4/10
3M's balance sheet carries meaningful leverage, with a Debt/Equity ratio of 2.65x — a level that warrants caution in a rising-rate or slowing-demand environment. The reported gross margin of 3,992% and net margin of 1,303% are almost certainly distorted by one-time accounting items (such as legal settlements or divestitures) rather than reflective of true operating performance, making margin analysis unreliable for this period...
Risk Assessment
- DATA INTEGRITY: Gross margin of 3,992% and net margin of 1,303% are almost certainly distorted by non-recurring items, making fundamental analysis of current-period profitability unreliable.
- EARNINGS DETERIORATION: Earnings growth of -2,058% year-over-year signals a severe bottom-line shock that overwhelms the headline revenue figure.
- DEBT: Debt/Equity of 2.65x reflects a highly leveraged balance sheet, increasing sensitivity to interest rate movements and credit conditions.
- TECHNICALS: Price of $149.17 sits below both the 50-day MA ($156.11) and 200-day MA ($157.29), with a confirmed death cross — a classically bearish structural signal.
- VALUATION OPACITY: With no DCF fair value, no TTM revenue or net income totals, and no FCF figure, it is impossible to construct a credible intrinsic value estimate with the currently available data.
---...
**Score: 4/10** 3M's balance sheet carries meaningful leverage, with a Debt/Equity ratio of 2.65x — a level that warrants caution in a rising-rate or slowing-demand environment. The reported gross margin of 3,992% and net margin of 1,303% are almost certainly distorted by one-time accounting items (such as legal settlements or divestitures) rather than reflective of true operating performance, making margin analysis unreliable for this period. Free cash flow is not available, removing a critical lens for assessing the company's ability to service debt and fund operations organically. ---
- **DATA INTEGRITY:** Gross margin of 3,992% and net margin of 1,303% are almost certainly distorted by non-recurring items, making fundamental analysis of current-period profitability unreliable. - **EARNINGS DETERIORATION:** Earnings growth of -2,058% year-over-year signals a severe bottom-line shock that overwhelms the headline revenue figure. - **DEBT:** Debt/Equity of 2.65x reflects a highly leveraged balance sheet, increasing sensitivity to interest rate movements and credit conditions. - **TECHNICALS:** Price of $149.17 sits below both the 50-day MA ($156.11) and 200-day MA ($157.29), with a confirmed death cross — a classically bearish structural signal. - **VALUATION OPACITY:** With no DCF fair value, no TTM revenue or net income totals, and no FCF figure, it is impossible to construct a credible intrinsic value estimate with the currently available data. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives